RecruitingNot ApplicableNCT06820983

Evaluation of the Quality of Life of Patients With DBB With the Installation of OPEP


Sponsor

Centre Hospitalier Universitaire, Amiens

Enrollment

60 participants

Start Date

Oct 17, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

To carry out an assessment of compliance and quality of life in a population (children and adults) with DDB before and after the use of an oscillating PEP. The aim is to determine the impact of the use of oscillating PEP on the daily life of this population in particular.


Eligibility

Min Age: 8 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying A satisfaction adherence questionnaire, Quality of life questionnaire for adolescents aged 14 to 17, and others for people with bronchiectasis, physiotherapy, and other related conditions. The study is currently recruiting participants at 1 location. People eligible for this study include aged 8 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERadult questionnary for parents of children aged 8 to 13

Quality of life questionnaire for parents of children aged 8 to 13

OTHERQuality of life questionnaire for children aged 8 to 13

Quality of life questionnaire for children aged 8 to 13

OTHERQuality of life questionnaire for adolescents aged 14 to 17

Quality of life questionnaire for adolescents aged 14 to 17

OTHERQuality of life questionnaire for adults

Quality of life questionnaire for adults

OTHERA satisfaction adherence questionnaire

A satisfaction adherence questionnaire will also be distributed to patients after several months' use of oscillating PEP


Locations(1)

CHU Amiens-Picardie

Amiens, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06820983


Related Trials